source
- Premium subscribers invited to exclusive post-hoc Q1 earnings recap live eventA live, post‑hoc session will be held for premium subscribers that reviews first‑quarter earnings across the pharmaceutical sector, with a particular focus on the deal activity reported in the call…
- Eli Lilly beats forecasts with 56% revenue jump, lifts full-year outlookEli Lilly reported first‑quarter revenue of $19.8 billion, up 56% year over year, and net income of $7.4 billion, or $8.26 a share. Non‑GAAP earnings were $8.55 a share, well above the $6.77 consen…